Enhanced ocular delivery of brinzolamide via β-cyclodextrin-based micelles for glaucoma management.

Brinzolamide (BRZ) is a carbonic anhydrase inhibitor for primary open-angle glaucoma (POAG) and ocular hypertension (OH). However, it suffers from poor aqueous solubility, leading to irritation and reduced patient compliance. This study introduces a…

Preview only. Read the full abstract at the source